Comparing the small sample performance of several variance estimators under competing risks

Statistics in Medicine

Volumn 26, Issue 5, 2007, Pages 1170-1180

  Braun, Thomas M ^a,b   Yuan, Zheng ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

^b NONE   (United States)

Author keywords

Bootstrap; Counting process; Cumulative incidence; Multinomial

Indexed keywords

BUSULFAN; CYCLOPHOSPHAMIDE;

ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ARTICLE; BONE MARROW TRANSPLANTATION; BOOTSTRAPPING; CLINICAL TRIAL; COMPARATIVE STUDY; DATA ANALYSIS; GRAFT VERSUS HOST REACTION; HIGH RISK PATIENT; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; MAJOR CLINICAL STUDY; MULTICENTER STUDY; RISK ASSESSMENT; SAMPLE SIZE; SIMULATION; STATISTICAL ANALYSIS; STATISTICAL DISTRIBUTION; SYSTEMATIC ERROR; VARIANCE;

ANALYSIS OF VARIANCE; MODELS, STATISTICAL; SAMPLE SIZE; UNITED STATES;

EID: 33847092869     PISSN: 02776715     EISSN: 10970258     Source Type: Journal    
DOI: 10.1002/sim.2661     Document Type: Article

References (32)

1. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. Journal of the American Statistical Association 1958; 53:457-481.
2. Tsiatis A. A nonidentifiability aspect of the problem of competing risks. Proceedings of the National Academy of Sciences of the United States of America 1975; 72:20-22.
3. Peterson AV. Bounds for a joint distribution function with fixed sub-distribution functions: applications to competing risks. Proceedings of the National Academy of Sciences 1976; 73:11-13.
4. Dignam J, Weissfeld LA, Anderson SJ. Methods for bounding the marginal survival distribution. Statistics in Medicine 1995; 14:1985-1998.
5. Horowitz MM, Gale RP, Sondel PM, Goldman JM, Kersey J, Kolb HJ, Rimm AA, Ringden O, Rozman C, Speck B, Truitt RL, Zwaan FE, Bortin MM. Graft-versus leukaemia reactions following bone marrow transplantation in humans. Blood 1989; 75:555-562.
6. Tai BC, Machin D, White I, Gebski V. Competing risks analysis of patients with osteosarcoma: a comparison of four different approaches. Statistics in Medicine 2001; 20:661-684.
7. Kim W, Poterucha JJ, Benson JT, Therneau TM. The impact of competing risks on the observed rate of chronic hepatitis C progression. Gastroenterology 2004; 127:749-755.
8. Kaempchen S, Guenther T, Toschke M, Grunkemeier GL, Wottke M, Lange R. Assessing the benefit of biological valve prostheses: cumulative incidence (actual) vs. Kaplan-Meier (actuarial) analysis. European Journal of Cardio-Thoracic Surgery 2003; 23:710-713.
9. Bailey RC, Jia-Yeong Lin M, Krakauer H. Time-to-event modeling of competing risks with intervening states in transplantation. American Journal of Transplantation 2003; 3:192-202.
10. Caplan RJ, Pajak TF, Cox JD. Analysis of the probability and risk of cause-specific failure. International Journal of Radiation Oncology, Biology, Physics 1994; 29:1183-1186.
11. Benichou J, Gail MH. Estimates of absolute cause-specific risk in cohort studies. Biometrics 1990; 46:379-386.
12. Korn EL, Dorey FJ. Application of crude incidence curves. Statistics in Medicine 1992; 11:813-829.
13. Gaynor JJ, Feuer EJ, Tan CC, Wu DH, Little CR, Straus DJ, Clarkson BD, Brennan MF. On the use of cause-specific failure and conditional failure probabilities: examples from clinical ontology data. Journal of the American Statistical Association 1993; 88:400-409.
14. Bentzen SM, Vaeth M, Pedersen DE, Overgaard J. Why actuarial estimate should be used in reporting late normal-tissue effects of cancer treatment. International Journal of Radiation Oncology, Biology, Physics 1995; 32:1531-1534.
15. Chappell R. Re: Caplan et al. and Bentzen et al. International Journal of Radiation Oncology, Biology, Physics 1996; 36:988-989.
16. Farley TMM, Mohamed MA, Slaymaker E. Competing approaches to analysis of failure times with competing risks. Statistics in Medicine 2001; 20:3601-3610.
17. Pepe MS, Mori M. Kaplan-Meier, marginal, or conditional probability curves in summarizing competing risk failure time data? Statistics in Medicine 1993; 12:737-751.
18. Aalen O. Nonparametric estimation of partial transition probabilities in multiple decrement models. Annals of Statistics 1978; 6:534-545.
19. Aalen O, Johansen S. An empirical transition matrix for nonhomogeneous Markov chains based on censored observations. Scandinavian Journal of Statistics 1978; 5:141-150.
20. Andersen PK, Borgan O, Gill R, Keiding N. Statistical Methods Based on Counting Processes. Springer: Berlin, 1993.
21. Gooley TA, Leisenring W, Crowley J, Storer BE. Estimation of failure probabilities in the presence of competing risks: new representations of old estimators. Statistics in Medicine 1999; 18:695-706.
22. Betensky RA, Schoenfeld DA. Nonparametric estimation in a cure model with random cure times. Biometrics 2001; 57:282-286.
23. Gray RJ. A class of k-sample tests for comparing the cumulative incidence of a competing risk. Annals of Statistics 1988; 16:1141-1154.
24. Pepe MS. Inference for events with dependent risks in multiple endpoint studies. Journal of the American Statistical Association 1991; 86:770-778.
25. Lin D. Non-parametric inference for cumulative incidence functions in competing risks studies. Statistics in Medicine 1997; 16:901-910.
26. Greenwood M. The natural duration of cancer. In Reports on Public Health and Medical Subjects 33. His Majesty's Stationery Office: London, 1926; 1-26.
27. Dinse GE, Larson MG. A note on semi-Markov models for partially censored data. Biometrika 1986; 73:379-386.
28. Choudhury JB. Non-parametric confidence interval estimation for competing risks analysis: application to contraceptive data. Statistics in Medicine 2002; 21:1129-1144.
29. Yuen KC, Zhu L, Zhang D. Comparing k cumulative incidence functions through resampling methods. Lifetime Data Analysis 2002; 8:401-412.
30. Efron B, Tibshirani RJ. An Introduction to the Bootstrap. Chapman & Hall: London, 1993.
31. Klein JP, Moeschberger ML. Survival Analysis: Techniques for Censored and Truncated Data (2nd edn). Springer: Berlin, 2003.
32. Copelan EA, Biggs JC, Thompson JM, Crilley P, Szer J, Klein JP, Kapoor N, Avalos BR, Cunningham I, Atkinson K, Downs K, Harmon GS, Daly MB, Brodsky I, Bulova SI, Utuschka PJ. Treatment for acute myelocytic leukaemia with allogeneic bone marrow transplantation following preparation with Bu/Cy. Blood 1991; 78:838-843.